Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
New distribution partnerships further global expansion plans for the Swoop system, growing the reach of Hyperfine to a total of...
Brain
Baszucki Group Launches Metabolic Mind Fresh Start Award to Recognize Individuals Who Have Reclaimed Their Mental Health with Ketogenic Therapy
The Fresh Start Award Program will grant up to five individuals a one-time prize of $10,000 to help them reach...
IRLAB Publishes Interim Report for the Period January-June 2024
GOTHENBURG, SWEDEN / ACCESSWIRE / July 10, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July 10, 2024 - IRLAB Therapeutics...
Psirenity Health Announces Lancaster Wellness Pharmacy as its Pharmacy Partner
Oakville, Ontario--(Newsfile Corp. - July 9, 2024) - Today, Psirenity Health is proud to announce that Lancaster Wellness Pharmacy will...
Personalized Obesity Care Genetic Testing Available to Women in New Phenomix Sciences and Hello Alpha Partnership
The first-of-its-kind collaboration combines personalized genetic insights with evidence-based treatments to provide accessible and effective obesity care for women MENLO...
European Patent Office: Female Tunisian innovators take third place in Young Inventors Prize 2024 with smart wheelchair technology
MUNICH, July 9, 2024 /PRNewswire/ -- The European Patent Office (EPO) today awarded the Tunisian team comprising Khaoula Ben Ahmed,...
Cresilon’s Revolutionary Hemostatic Gel Technology Shows Promising Results for Treatment of Penetrating Traumatic Brain Injury in Study Performed with Walter Reed Army Institute of Research
Findings from preclinical study demonstrate potential for a field and prehospital treatment following a penetrating TBI NEW YORK, July 9,...
Hop on a Cure Makes Financial Contribution Toward ALS CURE Project
ATLANTA, GA / ACCESSWIRE / July 9, 2024 / Hop On A Cure, a leading advocate in the fight against...
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical...
American Shared Hospital Services Announces Signing of Joint Venture Agreement for Gamma Knife Facility in Guadalajara, Mexico
JV will Establish Company’s 4th International CenterSAN FRANCISCO, July 09, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS)...
Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
MALVERN, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”),...
Seyltx Announces Results of Electronic Health Record Analysis to Determine the Prevalence of Refractory Chronic Cough
- Data will be presented at the London International Cough Symposium on July 18, 2024 - 54,958,289 adult patients in...
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease
~ Achieved statistically significant, dose-dependent, and durable evidence of potential therapeutic benefit; Patients receiving high-dose AMT-130 showed 80% slowing of...
Gain Therapeutics Announces the Completion of Dosing in the Multiple Ascending Dose (MAD) of the Phase 1 Study of GT-02287, a Novel Small Molecule Therapy for Parkinson’s Disease
GT-02287 Well Tolerated With No Serious Adverse Events or Other Safety Signals Reported Additional Topline Data To Be Presented Mid-August...
STALICLA appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors
Sarma1 2 Dr. Purnanand Sarma, PhD Press Release Dr. Sarma brings exceptional expertise in all facets of the pharmaceutical and...
New4med GmbH Announces First Cases of its novel Basivertebral Nerve Ablation (BVNA)
LADENBURG, Germany, July 8, 2024 /PRNewswire/ -- New4med GmbH, a German startup focused on innovative spinal treatments, announces the successful European...
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future...
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of Fibromyalgia
Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia Approximately 10 million adults in...
Rhythm Pharmaceuticals Announces Appointment of Alastair Garfield, Ph.D., as Chief Scientific Officer
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the...